What is the likely diagnostic rhythm issue in an adult patient with a history of cardiac issues presenting with telemetry evidence of short runs of regular tachycardia at a cycle length of 320-330 ms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Assessment of Regular Tachycardia at 320-330 ms Cycle Length

A cycle length of 320-330 ms corresponds to a heart rate of approximately 180-190 bpm, which in an adult with cardiac history most likely represents supraventricular tachycardia (SVT), specifically AVNRT or AVRT, though atrial flutter with 1:1 conduction and atrial tachycardia must also be considered. 1

Rate Calculation and Initial Classification

  • A cycle length of 320-330 ms translates to a rate of 180-190 bpm (calculated as 60,000 ms/minute ÷ cycle length) 1
  • This rate range is characteristic of paroxysmal SVT mechanisms, particularly those involving the AV node 1
  • The "short runs" description suggests paroxysmal episodes with spontaneous termination, which is highly characteristic of AVNRT or AVRT 1, 2

Most Likely Diagnoses in Order of Probability

Primary Considerations

AVNRT (Atrioventricular Nodal Reentrant Tachycardia):

  • This is the most common mechanism for regular SVT at this rate in adults with cardiac history 1, 3
  • Typical AVNRT commonly presents with rates of 150-250 bpm, making 180-190 bpm well within the expected range 1
  • The paroxysmal nature ("short runs") strongly supports this diagnosis 1, 2

AVRT (Atrioventricular Reciprocating Tachycardia):

  • Orthodromic AVRT is the second most common cause of regular narrow-complex tachycardia at this rate 1, 4
  • This mechanism involves an accessory pathway conducting retrogradely 4
  • Rates are typically similar to AVNRT 1, 4

Atrial Flutter with 1:1 Conduction:

  • Typical atrial flutter has an atrial rate around 300 bpm (cycle length ~200 ms), which would produce 2:1 conduction at 150 bpm 1
  • However, 1:1 conduction can occur, particularly in younger patients or those on antiarrhythmic drugs that slow the flutter rate 1
  • A cycle length of 320-330 ms could represent slowed atrial flutter with 1:1 AV conduction 1

Atrial Tachycardia:

  • Focal atrial tachycardia can present at rates of 180-190 bpm with 1:1 AV conduction 1
  • Less common than AVNRT/AVRT but must be considered 1, 3

Critical Diagnostic Steps Required

Immediate ECG Analysis Needed

Obtain 12-lead ECG during tachycardia:

  • This is the single most critical diagnostic step that determines all subsequent management 5
  • QRS duration <120 ms confirms SVT; ≥120 ms requires differentiation from ventricular tachycardia 1, 5

Assess P-wave relationship to QRS:

  • P waves buried in QRS (RP <90 ms) → typical AVNRT 1, 5
  • P waves in early ST segment (short RP) → AVRT or atypical AVNRT 1, 5
  • Atrial rate exceeding ventricular rate → atrial flutter or atrial tachycardia 1
  • "Sawtooth" pattern in inferior leads → atrial flutter 1

Exclude Dangerous Mimics

Rule out ventricular tachycardia if wide-complex:

  • VT accounts for >80% of wide-complex tachycardias and misdiagnosis can be fatal 1, 6
  • Look for AV dissociation, fusion complexes, or concordance in precordial leads 1
  • Apply Brugada or Vereckei criteria if QRS ≥120 ms 1

Assess for pre-excitation:

  • Review baseline ECG for delta waves indicating accessory pathway 5, 4
  • Pre-excitation with palpitations requires immediate electrophysiology referral due to sudden death risk 5

Clinical Context Considerations

Patient History Red Flags

  • Syncope during episodes: Warrants urgent cardiology referral regardless of mechanism 5
  • "Neck pounding" sensation: Highly specific for AVNRT due to cannon A-waves 5
  • Sudden onset/termination: Characteristic of AVNRT and AVRT 1, 2
  • Episodes while driving: Occurs in 57% of SVT patients; 14% experience syncope while driving 1, 5

Age and Structural Heart Disease

  • Elderly patients with AVNRT are more prone to syncope despite slower rates 5
  • Structural heart disease assessment via echocardiography is recommended for all documented sustained SVT 5

Common Diagnostic Pitfalls

  • Mistaking regular SVT for irregular rhythm: Rapid atrial fibrillation can appear regular and be misdiagnosed as SVT 1
  • Assuming narrow-complex = benign: Even narrow-complex SVT requires proper diagnosis and may need ablation 5, 3
  • Delaying ECG documentation: Repeated attempts at capturing the rhythm may be unnecessary if history is classic for SVT 2
  • Over-reliance on stability criteria: In patients with structural heart disease, VT can show cycle length variability and be misclassified as SVT 7

Management Implications

  • If hemodynamically unstable, immediate synchronized cardioversion is indicated 1
  • If stable, vagal maneuvers followed by IV adenosine is first-line acute treatment 1
  • Catheter ablation has 94.3-98.5% success rate and is preferred definitive treatment for recurrent symptomatic SVT 5, 3
  • Long-term pharmacotherapy with calcium channel blockers, beta-blockers, or antiarrhythmics is an alternative if ablation is declined 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Supraventricular tachycardia.

The Medical journal of Australia, 2009

Research

Accessory pathway reciprocating tachycardia.

European heart journal, 1998

Guideline

Evaluation of Supraventricular Tachycardia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Differentiating SVT from VT--a personal viewpoint.

European heart journal, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.